Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

102
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
102
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

179
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
179
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

211
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
211
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

85
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
85
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

2.0K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single Treatment of Mature 3D Single-, Dual- and Poly-Species Biofilms Using a Combination Therapy of Phage or Phage-Hetero-Cocktails and Ciprofloxacin.

Antibiotics (Basel, Switzerland)·2026
Same author

Defiance of stable lysogeny reveals hidden infection dynamics of phage Lambda.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Towards a reference methodology for bacteriophage susceptibility testing - position paper of the EUCAST Phage Susceptibility Testing Subcommittee.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Cortex modulation shapes UV-C and heat resistance properties of Bacillus cereus endospores.

Food research international (Ottawa, Ont.)·2026
Same author

Pyrogenicity of phage active pharmaceutical ingredients used for personalized therapy in Belgium.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026
Same author

A genomically unique lytic bacteriophage infecting Pseudomonas syringae pv. actinidiae.

Virology·2026

Related Experiment Video

Updated: Apr 27, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

9.8K

Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens.

Yves Briers1, Maarten Walmagh1, Victor Van Puyenbroeck1

  • 1Laboratory of Gene Technology, KU Leuven, Leuven, Belgium.

Mbio
|July 3, 2014
PubMed
Summary

Novel Artilysins, engineered from phage endolysins, effectively combat multidrug-resistant Gram-negative bacteria like Pseudomonas aeruginosa and Acinetobacter baumannii by penetrating their outer membrane for cell wall hydrolysis.

More Related Videos

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
07:47

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Published on: January 1, 2016

11.3K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

29.0K

Related Experiment Videos

Last Updated: Apr 27, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

9.8K
Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
07:47

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Published on: January 1, 2016

11.3K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

29.0K

Area of Science:

  • Biochemistry
  • Microbiology
  • Drug Discovery

Background:

  • Multidrug-resistant bacteria pose a significant global public health threat.
  • Bacterial viruses (phages) produce endolysins that kill Gram-positive bacteria but struggle against Gram-negative pathogens due to their outer membrane.
  • Novel antibacterial strategies are urgently needed to overcome antibiotic resistance.

Purpose of the Study:

  • To engineer endolysins to overcome the outer membrane barrier of Gram-negative bacteria.
  • To develop Artilysins as potent antibacterials against challenging Gram-negative pathogens.
  • To optimize Artilysin structure for enhanced bactericidal activity.

Main Methods:

  • Protein engineering of endolysins by fusing them with peptide components.
  • Development of Artilysins combining polycationic nonapeptides and modular endolysins.
  • In vitro and in vivo efficacy testing against multidrug-resistant Gram-negative bacteria, including Pseudomonas aeruginosa and Acinetobacter baumannii.

Main Results:

  • Artilysins demonstrated potent bactericidal activity against Gram-negative pathogens, achieving 4-5 log reductions within 30 minutes.
  • Enhanced activity was observed with specific linker lengths and combinations of polycationic and hydrophobic peptides.
  • Time-lapse microscopy confirmed Artilysins' mechanism: outer membrane penetration, peptidoglycan degradation, and cell lysis.

Conclusions:

  • Artilysins represent a promising new class of antibacterials effective against multidrug-resistant Gram-negative bacteria.
  • Engineered endolysins (Artilysins) successfully overcome the outer membrane barrier, offering a novel therapeutic approach.
  • Artilysins show efficacy in both in vitro and in vivo models, highlighting their therapeutic potential.